Principal Securities, Inc. Adma Biologics, Inc. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 41 shares of ADMA stock, worth $596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41
Previous 22
86.36%
Holding current value
$596
Previous $377,000
98.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
400Shares Held
196MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$311 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$271 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$186 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...